Income Statement (ELEDON/PHARMACEUTICALS)

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Eledon Pharmaceuticals in a report released on Sunday, March 23rd. Lee… [+3005 chars]...

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Leerink Partnrs decreased their FY2025 earnings estimates for Eledon Pharmaceuticals in a research report issued to … [+3139 chars]...

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Cantor Fitzgerald decreased their FY2025 earnings per share (EPS) estimates for Eledon Pharmaceuticals in a note iss… [+3083 chars]...

Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "Kidney Transplant Rejection - Market Insight, Epidemiology, and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. Th… [+11255 chars]...

New York, USA, April 10, 2025 (GLOBE NEWSWIRE) -- Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight The global market for prefilled syringes is expanding, driven by the… [+12559 chars]...

New York, USA, April 17, 2025 (GLOBE NEWSWIRE) -- Infusion Pumps Market to Soar at a CAGR of ~10% by 2032, Owing to the Advancements in Technology and Increased Demand in Healthcare | DelveInsight T… [+16623 chars]...